Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content


 

Early Release

Current Weekly

  • Contact Lens–Related Corneal Infections — United States, 2005–2015

    	The figure above is a photograph of a woman putting in a contact lens.August 19, 2016
    A total of 1,075 Medical Device Reports (MDRs) describing contact lens–related corneal infections were reported to the Food and Drug Administration’s MDR database during 2005–2015. Approximately 20% of those reports described a patient who suffered eye damage. Roughly 25% described potentially modifiable factors that might have put the patient at risk for a contact lens–related corneal infection.

  • Tobacco Advertising and Promotional Expenditures in Sports and Sporting Events — United States, 1992–2013

    	The figure above is a photograph of a boy watching a baseball game.August 19, 2016
    In March 2010, the Food and Drug Administration prohibited tobacco-brand sponsorship of regulated tobacco products in sports and entertainment events or other social or cultural events. During 1992–2013, adjusted sports-related marketing expenditures decreased significantly for both cigarettes (from $136 million in 1992 to $0 during 2010–2013) and smokeless tobacco (from $34.8 million in 1992 to $2.1 million in 2013).

More

Surveillance Summaries

  • Surveillance for Violent Deaths — National Violent Death Reporting System, 17 States, 2013

    August 19, 2016
    In 2013, more than 57,000 persons died in the United States as a result of violence-related injuries. This report summarizes data from CDC’s National Violent Death Reporting System (NVDRS) regarding violent deaths from 17 U.S. states for 2013. The majority of these deaths were suicides, followed by homicides. Results are reported by sex, age group, race/ethnicity, marital status, location where injury occurred, method used, and other selected characteristics.

Recommendations and Reports

  • U.S. Medical Eligibility Criteria for Contraceptive Use, 2016

    July 29, 2016
    The 2016 U.S. Medical Eligibility Criteria for Contraceptive Use (U.S. MEC) comprises recommendations for the use of specific contraceptive methods by women and men who have certain characteristics or medical conditions. Notable updates since the 2010 U.S. MEC include the addition of recommendations for women with cystic fibrosis, women with multiple sclerosis, and women receiving certain psychotropic drugs or St. John’s wort; revisions to the recommendations for emergency contraception, including the addition of ulipristal acetate; and revisions to the recommendations for postpartum women; women who are breastfeeding; women with known dyslipidemias, migraine headaches, superficial venous disease, gestational trophoblastic disease, sexually transmitted diseases, and human immunodeficiency virus; and women who are receiving antiretroviral therapy. These recommendations are a companion document to the CDC U.S. Selected Practice Recommendations for Contraceptive Use, 2016.


    U.S. Selected Practice Recommendations for Contraceptive Use, 2016

    July 29, 2016
    The 2016 U.S. Selected Practice Recommendations for Contraceptive Use (U.S. SPR) addresses common issues regarding initiation and use of specific contraceptive methods. The information in this report updates the 2013 U.S. SPR. Major updates include 1) revised recommendations for starting regular contraception after the use of emergency contraceptive pills and 2) new recommendations for the use of medications to ease insertion of intrauterine devices. These recommendations are a companion document to the CDC U.S. Medical Eligibility Criteria for Contraceptive Use, 2016.

Supplements

Notifiable Diseases

Top